China Pharma Holdings (CPHI) Revenue Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1.62% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 14.92% |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -13.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.44% |
| Dec 31, 2025 | 8.11% |
| Sep 30, 2025 | -31.26% |
| Jun 30, 2025 | 10.90% |
| Mar 31, 2025 | -17.05% |
| Dec 31, 2024 | -47.25% |
| Sep 30, 2024 | -39.00% |
| Jun 30, 2024 | -15.75% |
| Mar 31, 2024 | -30.12% |
| Dec 31, 2023 | -26.41% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | -31.94% |
| Mar 31, 2023 | 22.21% |
| Dec 31, 2022 | 1.09% |
| Sep 30, 2022 | -0.64% |
| Jun 30, 2022 | -33.22% |
| Mar 31, 2022 | -31.99% |
| Dec 31, 2021 | -1.42% |
| Sep 30, 2021 | -17.58% |
| Jun 30, 2021 | -35.94% |